ImmunityBio, Inc. IBRX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $7.92B.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s market capitalization?
- ImmunityBio, Inc. (IBRX) reported market capitalization of $7.92B in Q1 2026.
- How has ImmunityBio, Inc.'s market capitalization changed year-over-year?
- ImmunityBio, Inc.'s market capitalization increased by 208.3% year-over-year, from $2.57B to $7.92B.
- What is the long-term trend for ImmunityBio, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s market capitalization has grown at a -17.5% compound annual growth rate (CAGR), from $5.1B to $1.95B.
- What does market capitalization mean?
- What the stock market says the company's equity is worth.
- How do you interpret market capitalization?
- A size and market-sentiment gauge, not a quality measure — interpret through valuation ratios (P/E, P/S) that relate it to fundamentals.
- How does market capitalization compare across companies?
- Comparable across companies as a size class; the input to every equity-price valuation multiple.